Plus Therapeutics Showcases New Interim Respect-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting
plus therapeutics 在 2024 年神經外科醫師年會上展示了新的 interim Respect-GBm 2 期試驗數據
Plus Therapeutics Showcases New Interim Respect-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting
plus therapeutics 在 2024 年神經外科醫師年會上展示了新的 interim Respect-GBm 2 期試驗數據
譯文內容由第三人軟體翻譯。